title: Notch1 confers a resistance to glucocorticoid-induced apoptosis on developing thymocytes by down-regulating SRG3 expression.
abstract: We previously have reported that SRG3 is required for glucocorticoid (GC)-induced apoptosis in the S49.1 thymoma cell line. Activation of Notch1 was shown to induce GC resistance in thymocytes. However, the specific downstream target of Notch1 that confers GC resistance on thymocytes is currently unknown. We found that the expression level of SRG3 was critical in determining GC sensitivity in developing thymocytes. The expression of SRG3 also was down-regulated by the activated form of Notch1 (NotchIC). The promoter activity of the SRG3 gene also was down-regulated by NotchIC. Expression of transgenic SRG3 resulted in the restoration of GC sensitivity in thymocytes expressing transgenic Notch1. These results suggest that SRG3 is the downstream target of Notch1 in regulating GC sensitivity of thymocytes.
authors.affiliation: Institute of Molecular Biology and Genetics and School of Biological Sciences, Seoul National University and International Vaccine Institute, Seoul 151-742, Korea.
authors.forename: Y I
authors.initials: YI
authors.lastname: Choi
authors.forename: S H
authors.initials: SH
authors.lastname: Jeon
authors.forename: J
authors.initials: J
authors.lastname: Jang
authors.forename: S
authors.initials: S
authors.lastname: Han
authors.forename: J K
authors.initials: JK
authors.lastname: Kim
authors.forename: H
authors.initials: H
authors.lastname: Chung
authors.forename: H W
authors.initials: HW
authors.lastname: Lee
authors.forename: H Y
authors.initials: HY
authors.lastname: Chung
authors.forename: S D
authors.initials: SD
authors.lastname: Park
authors.forename: R H
authors.initials: RH
authors.lastname: Seong
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001483:Base Sequence; D002454:Cell Differentiation; D002460:Cell Line; D017931:DNA Primers / Q000235:genetics; D003907:Dexamethasone / Q000494:pharmacology; D015536:Down-Regulation / Q000187:drug effects; D004351:Drug Resistance; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051881:Receptor, Notch1; D011956:Receptors, Cell Surface; D012097:Repressor Proteins; D013601:T-Lymphocytes / Q000166:cytology* / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D015534:Trans-Activators / Q000235:genetics*; D014157:Transcription Factors
chemical_list: D017931:DNA Primers; D005938:Glucocorticoids; D008565:Membrane Proteins; C497762:Notch1 protein, mouse; D012333:RNA, Messenger; D051881:Receptor, Notch1; D011956:Receptors, Cell Surface; D012097:Repressor Proteins; D015534:Trans-Activators; D014157:Transcription Factors; D003907:Dexamethasone